HAEMONETICS CORP - 8-K Filing
Haemonetics Corporation announced changes to its reportable segment structure, effective beginning in Q1 of fiscal year 2027. Previously separate Plasma and Blood Center segments will be combined into a single Apheresis segment, while the Hospital segment is renamed MedSurg. The company has recast historical quarterly revenue data from FY2024 through FY2026 and updated its FY2027 guidance under the new structure. (Items: 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $HAE